Transcriptome-based NGS outperforms traditional viral testing with superior sensitivity, detecting viruses including novel ...

With the US poised to lose its measles-free status, an expert from GeoVax discusses how to win back the minds of Americans.

Biopharmaceutical company Rakuten announced the signing of a manufacturing partnership with contract development and ...

North Carolina Governor Josh Stein announced that pharmaceutical giant Johnson & Johnson (J&J) will expand its presence in ...

Last week, biotechnology company Ascidian Therapeutics announced a manufacturing partnership with gene-therapy–focused ...

Meanwhile, Novotech has appointed Anand Tharmaratnam as its own new CEO. Tharmaratnam has over 30 years of industry ...

The Priority Review Voucher (PRV) program is designed to incentivize rare disease drug development.

Ludwig Macko is head of development for Genedata's Selector software platform for NGS data analysis.

Valentina Armiento is science communications manager at Genedata.

But cell and gene therapies (CGTs) are catching up. During Cell and Gene Therapy International Europe 2025, held in Berlin, ...